An 83-year-old man was admitted to our hospital due to a recurrence of multiple myeloma, accompanied by the appearance of plasma cells in the peripheral blood (PB). Subsequently, he was diagnosed with secondary plasma cell leukemia (sPCL). A chemotherapy regimen of carfilzomib and dexamethasone (Cd) combination therapy was selected, and 15 days later, plasma cells completely disappeared from the PB. Cd therapy was continued, and the free kappa chain levels normalized. Three months later, M-protein could not be detected using serum electrophoresis. This is a valuable report wherein Cd combination therapy was successful in treating sPCL.

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.63.111DOI Listing

Publication Analysis

Top Keywords

secondary plasma
8
plasma cell
8
cell leukemia
8
carfilzomib dexamethasone
8
plasma cells
8
combination therapy
8
[rapid response
4
response secondary
4
plasma
4
leukemia carfilzomib
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!